SR9009 (Stenabolic)

SR9009,  also known as Stenabolic, is a new drug currently being developed at  TSRI (The Scripps Research Institute). It has been shown to considerably  boost exercise endurance in animal models, leading scientists to  believe that SR9009 could improve individuals suffering from illnesses  limiting physical movement including obesity, COPD (chronic obstructive  pulmonary disease), congestive heart failure and slow the deterioration  of age related muscle capacity. 

Stenabolic was first developed by Professor Thomas Burris who first used  it to experiment with mice. Within days, the treated mice became  leaner, developed larger muscles and had a 50% increase in running  ability.

SR9009 basically imitates the effects of aerobic exercise. 

It does this by binding itself to Rev-erbα, which is responsible for lipid and glucose metabolism, the creation of fat-storing cells and the reaction of macrophages during inflammation. 

SR9009 affects the primary biological clock, which coordinates the  rhythm of the body’s activity with the 24-hour phase of day and night.

Recent research show that activation of Rev-erbα with SR9009 resulted  to enhanced metabolic activity in skeletal muscle tissue in both  culture and in mice. The authors of this new research propose that  Rev-erbα affects muscle cells by stimulating both the formation of new  mitochondria (more known as the “power plants” of the cell) and the  authorization of those mitochondria that are flawed.

If the effects of SR9009 on mice can securely be duplicated for  people, the new drug may provide new treatments for obesity and its  companions, metabolic syndrome and diabetes. Another area in which  SR9009 or a similar drug may present significant benefit is to balance  the loss of overall muscle conditioning which transpires as a side  effect of reduced activity due to sickness or old age.

Hoping that small-scale medical trials on people start ASAP!

I know you must be wondering if taking Stenabolic is going to cause  any problematic side effects while on cycle. And the truth is, there are  no recorded adverse effects as a result of taking SR 9009.

It is still a relatively new drug currently undergoing testing, but has been deemed 100% safe up till this point.

SR9009 is meant to be run on a minumum of 12 weeks. As with any SARM  or anabolic compound, you should always assess your animal’s tolerance  first by starting at 10mg and working your way up.

A good sweet spot is somewhere around the 20mg per day area.

Stenabolic is not as anabolic as some of the other SARMs, and  therefore is perfect for cutting or recomping during a cycle. If you do  want to put on added weight while using SR 9009, then be sure stick to a  diet of high calories and protein.